• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

负载白喉类毒素的聚(ε-己内酯)纳米颗粒作为黏膜疫苗递送系统。

Diphtheria toxoid loaded poly-(epsilon-caprolactone) nanoparticles as mucosal vaccine delivery systems.

作者信息

Singh Jasvinder, Pandit Sreenivas, Bramwell Vincent W, Alpar H Oya

机构信息

Centre for Drug Delivery Research, University of London School of Pharmacy, London WC1N 1AX, UK.

出版信息

Methods. 2006 Feb;38(2):96-105. doi: 10.1016/j.ymeth.2005.11.003.

DOI:10.1016/j.ymeth.2005.11.003
PMID:16442811
Abstract

Poly-(epsilon-caprolactone) (PCL), a poly(lactide-co-glycolide) (PLGA)-PCL blend and co-polymer nanoparticles encapsulating diphtheria toxoid (DT) were investigated for their potential as a mucosal vaccine delivery system. The nanoparticles, prepared using a water-in-oil-in-water (w/o/w) double emulsion solvent evaporation method, demonstrated release profiles which were dependent on the properties of the polymers. An in vitro experiment using Caco-2 cells showed significantly higher uptake of PCL nanoparticles in comparison to polymeric PLGA, the PLGA-PCL blend and co-polymer nanoparticles. The highest uptake mediated by the most hydrophobic nanoparticles using Caco-2 cells was mirrored in the in vivo studies following nasal administration. PCL nanoparticles induced DT serum specific IgG antibody responses significantly higher than PLGA. A significant positive correlation between hydrophobicity of the nanoparticles and the immune response was observed following intramuscular administration. The positive correlation between hydrophobicity of the nanoparticles and serum DT specific IgG antibody response was also observed after intranasal administration of the nanoparticles. The cytokine assays showed that the serum IgG antibody response induced is different according to the route of administration, indicated by the differential levels of IL-6 and IFN-gamma. The nanoparticles eliciting the highest IgG antibody response did not necessarily elicit the highest levels of the cytokines IL-6 and IFN-gamma.

摘要

研究了聚(ε-己内酯)(PCL)、聚(丙交酯-共-乙交酯)(PLGA)-PCL共混物以及包裹白喉类毒素(DT)的共聚物纳米颗粒作为粘膜疫苗递送系统的潜力。采用水包油包水(w/o/w)双乳液溶剂蒸发法制备的纳米颗粒,其释放曲线取决于聚合物的性质。使用Caco-2细胞进行的体外实验表明,与聚合物PLGA、PLGA-PCL共混物和共聚物纳米颗粒相比,PCL纳米颗粒的摄取量显著更高。在鼻腔给药后的体内研究中,使用Caco-2细胞的最疏水纳米颗粒介导的最高摄取量得到了体现。PCL纳米颗粒诱导的DT血清特异性IgG抗体反应显著高于PLGA。肌肉注射后,观察到纳米颗粒的疏水性与免疫反应之间存在显著正相关。在纳米颗粒鼻腔给药后,也观察到纳米颗粒的疏水性与血清DT特异性IgG抗体反应之间的正相关。细胞因子检测表明,根据给药途径的不同,诱导的血清IgG抗体反应也不同,这由IL-6和IFN-γ的不同水平表明。引发最高IgG抗体反应的纳米颗粒不一定引发最高水平的细胞因子IL-6和IFN-γ。

相似文献

1
Diphtheria toxoid loaded poly-(epsilon-caprolactone) nanoparticles as mucosal vaccine delivery systems.负载白喉类毒素的聚(ε-己内酯)纳米颗粒作为黏膜疫苗递送系统。
Methods. 2006 Feb;38(2):96-105. doi: 10.1016/j.ymeth.2005.11.003.
2
Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.壳聚糖包被聚己内酯纳米粒系统的研制及其对流感的有效免疫作用。
Vaccine. 2011 Nov 8;29(48):9026-37. doi: 10.1016/j.vaccine.2011.09.033. Epub 2011 Sep 20.
3
Mucosal or systemic administration of rE2 glycoprotein antigen loaded PLGA microspheres.负载重组E2糖蛋白抗原的聚乳酸-羟基乙酸共聚物微球的黏膜或全身给药。
Int J Pharm. 2009 May 21;373(1-2):16-23. doi: 10.1016/j.ijpharm.2009.01.020. Epub 2009 Feb 4.
4
Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.给药途径影响免疫应答的质量:颗粒性抗原递呈系统的横断面评价。
J Control Release. 2010 Nov 1;147(3):342-9. doi: 10.1016/j.jconrel.2010.08.012. Epub 2010 Aug 18.
5
Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.对经鼻给予的含有重组乙型肝炎抗原的表面修饰聚乳酸-羟基乙酸共聚物(PLGA)微球产生强烈的全身和黏膜免疫反应。
Vaccine. 2006 May 8;24(19):4201-11. doi: 10.1016/j.vaccine.2006.01.011. Epub 2006 Jan 18.
6
In vivo uptake of an experimental microencapsulated diphtheria vaccine following sub-cutaneous immunisation.皮下免疫后实验性微囊化白喉疫苗的体内摄取情况。
Vaccine. 2004 Jun 23;22(19):2430-7. doi: 10.1016/j.vaccine.2003.11.068.
7
Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.鼻腔接种用 N-三甲基壳聚糖和 PLGA 基纳米粒:纳米粒特性决定了包封抗原在小鼠体内的抗体应答的质量和强度。
Vaccine. 2010 Aug 31;28(38):6282-91. doi: 10.1016/j.vaccine.2010.06.121. Epub 2010 Jul 16.
8
PLGA:poloxamer and PLGA:poloxamine blend nanostructures as carriers for nasal gene delivery.聚乳酸-羟基乙酸共聚物:泊洛沙姆以及聚乳酸-羟基乙酸共聚物:泊洛胺共混纳米结构作为鼻腔基因递送载体
J Control Release. 2006 Jun 28;113(2):164-72. doi: 10.1016/j.jconrel.2006.03.017. Epub 2006 Apr 5.
9
The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-epsilon-caprolactone-based nanoparticles.通过鼻内给予聚ε-己内酯基纳米颗粒增强针对马链球菌抗原的免疫反应。
Biomaterials. 2009 Feb;30(5):879-91. doi: 10.1016/j.biomaterials.2008.10.035. Epub 2008 Nov 22.
10
Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.用于口服递送抗癌药物的聚(d,l-丙交酯-共-乙交酯)/蒙脱石纳米颗粒
Biomaterials. 2005 Oct;26(30):6068-76. doi: 10.1016/j.biomaterials.2005.03.021.

引用本文的文献

1
Oral administration of a recombinant modified RBD antigen of SARS-CoV-2 as a possible immunostimulant for the care of COVID-19.口服一种新型 SARS-CoV-2 重组 RBD 抗原作为 COVID-19 护理的可能免疫刺激剂。
Microb Cell Fact. 2024 Feb 6;23(1):41. doi: 10.1186/s12934-024-02320-5.
2
Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine.口服亚单位 SARS-CoV-2 疫苗可诱导全身中和 IgG、IgA 和细胞免疫应答,并能增强已接种疫苗产生的中和抗体应答。
Vaccine. 2022 Feb 16;40(8):1098-1107. doi: 10.1016/j.vaccine.2022.01.025. Epub 2022 Jan 19.
3
Preparation of Poly-Lactic-Co-Glycolic Acid Nanoparticles in a Dry Powder Formulation for Pulmonary Antigen Delivery.
用于肺部抗原递送的干粉制剂形式的聚乳酸-乙醇酸共聚物纳米颗粒的制备
Pharmaceutics. 2021 Aug 3;13(8):1196. doi: 10.3390/pharmaceutics13081196.
4
Biodegradable polymers for modern vaccine development.用于现代疫苗开发的可生物降解聚合物。
J Ind Eng Chem. 2019 Sep 25;77:12-24. doi: 10.1016/j.jiec.2019.04.044. Epub 2019 Apr 28.
5
Evaluation of nanoselenium and nanogold activities against murine intestinal schistosomiasis.纳米硒和纳米金对小鼠肠道血吸虫病活性的评估。
Saudi J Biol Sci. 2019 Nov;26(7):1468-1472. doi: 10.1016/j.sjbs.2018.02.008. Epub 2018 Feb 21.
6
Non-invasive administration of biodegradable nano-carrier vaccines.可生物降解纳米载体疫苗的非侵入性给药。
Am J Transl Res. 2017 Jan 15;9(1):15-35. eCollection 2017.
7
Mitochondrion: A Promising Target for Nanoparticle-Based Vaccine Delivery Systems.线粒体:基于纳米粒子的疫苗传递系统的有前途的靶标。
Vaccines (Basel). 2016 Jun 1;4(2):18. doi: 10.3390/vaccines4020018.
8
Macrophage-derived reactive oxygen species protects against autoimmune priming with a defined polymeric adjuvant.巨噬细胞衍生的活性氧可通过一种特定的聚合物佐剂预防自身免疫致敏。
Immunology. 2016 Jan;147(1):125-32. doi: 10.1111/imm.12546. Epub 2015 Nov 24.
9
Intraocular Implants for the Treatment of Autoimmune Uveitis.用于治疗自身免疫性葡萄膜炎的眼内植入物
J Funct Biomater. 2015 Jul 31;6(3):650-66. doi: 10.3390/jfb6030650.
10
Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies.基于蛋白质抗原的鼻内和口服疫苗接种:优势、挑战与制剂策略
Protein Cell. 2015 Jul;6(7):480-503. doi: 10.1007/s13238-015-0164-2. Epub 2015 May 6.